5,173
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Guselkumab, tildrakizumab, and risankizumab in a real-world setting: drug survival and effectiveness in the treatment of psoriasis and psoriatic arthritis

ORCID Icon, ORCID Icon & ORCID Icon
Article: 2133531 | Received 22 Jul 2022, Accepted 30 Sep 2022, Published online: 18 Oct 2022

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.